Please login to the form below

Not currently logged in
Email:
Password:

untreated diffuse large B-cell lymphoma

This page shows the latest untreated diffuse large B-cell lymphoma news and features for those working in and with pharma, biotech and healthcare.

Roche’s Polivy receives EC approval for lymphoma therapy

Roche’s Polivy receives EC approval for lymphoma therapy

The combination therapy is for patients with previously untreated diffuse large B-cell lymphoma. ... Following a wait of 20 years for a clinically meaningful improvement for patients with untreated diffuse large B-cell lymphoma (DLBCL), the European

Latest news

  • Roche's Gazyvaro flunks trial in non-Hodgkin's lymphoma Roche's Gazyvaro flunks trial in non-Hodgkin's lymphoma

    Roche's hopes of extending the use of its Gazyvaro into the most common form of non-Hodgkin's lymphoma have been dashed after it failed a late-stage trial. ... Gazyvaro (obinutuzumab) - sold as Gazyva in the US - was unable to improve progression-free

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Evoke Mind+Matter

We are Evoke Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....